Literature DB >> 21128048

[Viral arthritides].

E Märker-Hermann1, N Schütz, H Bauer.   

Abstract

Viruses are common etiologic agents of acute polyarthritis worldwide. Rheumatic symptoms are often accompanied by other viral symptoms such as fever, rash, myalgia or nausea, but isolated arthritis may occur resembling or imitating early rheumatoid arthritis. In Europe and North America, the most common arthritogenic viruses include parvovirus B19, rubella, hepatitis B and C, whereas mosquito-borne alpha-viruses are endemic in Africa, Australia, the western Pacific and South America. The latter have attracted the interest of European rheumatologists due to the increasing number of tourists travelling to these regions. Viruses may cause arthritis via various mechanisms, including direct synovial infection leading to cell lysis, immune complex formation or pro-inflammatory cytokine induction. Indirect viral pathogenic effects may induce autoimmune reactions via bystander activation or epitope spreading.

Entities:  

Mesh:

Year:  2010        PMID: 21128048     DOI: 10.1007/s00393-010-0701-6

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.530


  27 in total

Review 1.  Hepatitis C virus infection.

Authors:  G M Lauer; B D Walker
Journal:  N Engl J Med       Date:  2001-07-05       Impact factor: 91.245

Review 2.  Virus-associated arthritis.

Authors:  Kayo Masuko-Hongo; Tomohiro Kato; Kusuki Nishioka
Journal:  Best Pract Res Clin Rheumatol       Date:  2003-04       Impact factor: 4.098

Review 3.  Human T cell leukemia virus type-I and rheumatoid arthritis.

Authors:  T Hasunuma; T Sumida; K Nishioka
Journal:  Int Rev Immunol       Date:  1998       Impact factor: 5.311

Review 4.  Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy.

Authors:  J A DeSimone; R J Pomerantz; T J Babinchak
Journal:  Ann Intern Med       Date:  2000-09-19       Impact factor: 25.391

Review 5.  An approach to the human immunodeficiency virus-positive patient with a spondyloarthropathic disease.

Authors:  G Solomon; L Brancato; R Winchester
Journal:  Rheum Dis Clin North Am       Date:  1991-02       Impact factor: 2.670

6.  Psoriatic arthritis and human immunodeficiency virus infection in Zambia.

Authors:  P Njobvu; P McGill
Journal:  J Rheumatol       Date:  2000-07       Impact factor: 4.666

7.  Infection with chikungunya virus in Italy: an outbreak in a temperate region.

Authors:  G Rezza; L Nicoletti; R Angelini; R Romi; A C Finarelli; M Panning; P Cordioli; C Fortuna; S Boros; F Magurano; G Silvi; P Angelini; M Dottori; M G Ciufolini; G C Majori; A Cassone
Journal:  Lancet       Date:  2007-12-01       Impact factor: 79.321

Review 8.  Rheumatic manifestations of hepatitis C infection.

Authors:  L B Siegel; L Cohn; D Nashel
Journal:  Semin Arthritis Rheum       Date:  1993-12       Impact factor: 5.532

9.  Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement.

Authors:  Michele Bombardieri; Cristiano Alessandri; Giancarlo Labbadia; Cristina Iannuccelli; Francesco Carlucci; Valeria Riccieri; Vincenzo Paoletti; Guido Valesini
Journal:  Arthritis Res Ther       Date:  2004-01-29       Impact factor: 5.156

Review 10.  Virally associated arthritis 2008: clinical, epidemiologic, and pathophysiologic considerations.

Authors:  Dimitrios Vassilopoulos; Leonard H Calabrese
Journal:  Arthritis Res Ther       Date:  2008-09-18       Impact factor: 5.156

View more
  1 in total

1.  A Study of the Impact of Graphene Oxide on Viral Infection Related to A549 and TC28a2 Human Cell Lines.

Authors:  Piotr Kuropka; Maciej Dobrzynski; Barbara Bazanow; Dominika Stygar; Tomasz Gebarowski; Anna Leskow; Malgorzata Tarnowska; Katarzyna Szyszka; Malgorzata Malecka; Nicole Nowak; Wieslaw Strek; Rafal J Wiglusz
Journal:  Materials (Basel)       Date:  2021-12-16       Impact factor: 3.623

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.